Dynamic changes in lysosome-related pathways in APP/PS1 mice with aging

Abstract

Senile plaque, composed of amyloid β protein (Aβ) aggregates, is a critical pathological feature in Alzheimer's disease (AD), leading to cognitive dysfunction. However, how Aβ aggregates exert age-dependent toxicity and temporal cognitive dysfunction in APP/PS1 mice remains incompletely understood. In this study, we investigated AD pathogenesis and dynamic alterations in lysosomal pathways within the hippocampus of age-gradient male mice using transcriptome sequencing, molecular biology assays, and histopathological analyses. We observed high levels of β-amyloid precursor protein (APP) protein expression in the hippocampus at an early stage and age-dependent Aβ deposition. Transcriptome sequencing revealed the enrichment of differential genes related to the lysosome pathway. Furthermore, the protein expression of ATP6V0d2 and CTSD associated with lysosomal functions exhibited dynamic changes with age, increasing in the early stage and decreasing later. Similar age-dependent patterns were observed for the endosome function, autophagy pathway, and SGK1/FOXO3a pathway. Nissl and Golgi staining in the hippocampal region showed age-dependent neuronal loss and synaptic damage, respectively. These findings clearly define the age-gradient changes in the autophagy–lysosome system, the endosome/lysosome system, and the SGK1/FOXO3a pathway in the hippocampus of APP/PS1 mice, providing new perspectives and clues for understanding the possible mechanisms of AD, especially the transition from compensatory to decompensated state.

Keywords

Alzheimer's disease / autophagy–lysosome system / Aβ / endosomal/lysosome system / SGK1/FOXO3a pathway / transcriptome sequencing

References

1	Y Zhang, Y Zhang, Y Aman, et al. Amyloid-β toxicity modulates tau phosphorylation through the PAX6 signalling pathway. Brain. 2021;144(9):2759-2770.
2	A Liu, Y Zhang, L Han, et al. Regulation of neurotransmitter release by amyloid precursor protein through synapsin phosphorylation. Neurochem Res. 2019;44(3):683-691.
3	VS Sukhorukov, NM Mudzhiri, AS Voronkova, TI Baranich, VV Glinkina, SN Illarioshkin. Mitochondrial disorders in Alzheimer's disease. Biochemistry (Moscow). 2021;86(6):667-679.
4	Z Zhang, X Yang, Y-Q Song, J Tu. Autophagy in Alzheimer's disease pathogenesis: therapeutic potential and future perspectives. Ageing Res Rev. 2021;72:101464.
5	PH Reddy, DM Oliver. Amyloid Beta and phosphorylated tau-induced defective autophagy and mitophagy in Alzheimer's disease. Cells. 2019;8(5):488.
6	V Soura, M Stewart-Parker, TL Williams, et al. Visualization of co-localization in Aβ42-administered neuroblastoma cells reveals lysosome damage and autophagosome accumulation related to cell death. Biochem J. 2012;441(2):579-590.
7	JM Carosi, TJ Sargeant. Rapamycin and Alzheimer's disease: a double-edged sword? Autophagy. 2019;15(8):1460-1462.
8	SD Ginsberg, MJ Alldred, SE Counts, et al. Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression. Biol Psychiatry. 2010;68(10):885-893.
9	RJ O'Brien, PC Wong. Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci. 2011;34:185-204.
10	AM Cataldo, S Petanceska, CM Peterhoff, et al. App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of Down syndrome. J Neurosci. 2003;23(17):6788-6792.
11	Y Sang, P Kong, S Zhang, et al. SGK1 in human cancer: emerging roles and mechanisms. Front Oncol. 2020;10:608722.
12	F Lang, N Strutz-Seebohm, G Seebohm, UE Lang. Significance of SGK1 in the regulation of neuronal function. J Physiol. 2010;588(Pt 18):3349-3354.
13	B Lian, M Liu, Z Lan, et al. Hippocampal overexpression of SGK1 ameliorates spatial memory, rescues Aβ pathology and actin cytoskeleton polymerization in middle-aged APP/PS1 mice. Behav Brain Res. 2020;383:112503.
14	P Sahin, C McCaig, J Jeevahan, JT Murray, AH Hainsworth. The cell survival kinase SGK1 and its targets FOXO3a and NDRG1 in aged human brain. Neuropathol Appl Neurobiol. 2013;39(6):623-633.
15	W Qin, V Haroutunian, P Katsel, et al. PGC-1alpha expression decreases in the Alzheimer's disease brain as a function of dementia. Arch Neurol. 2009;66(3):352-361.
16	BE Fitzwalter, A Thorburn. FOXO3 links autophagy to apoptosis. Autophagy. 2018;14(8):1467-1468.
17	N Matsumoto, M Sekiya, K Tohyama, et al. Essential role of the a3 isoform of V-ATPase in secretory lysosome trafficking via Rab7 recruitment. Sci Rep. 2018;8(1):6701.
18	V Boccardi, L Pelini, S Ercolani, C Ruggiero, P Mecocci. From cellular senescence to Alzheimer's disease: the role of telomere shortening. Ageing Res Rev. 2015;22:1-8.
19	J Ramesh Babu, M Lamar Seibenhener, J Peng, et al. Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration. J Neurochem. 2008;106(1):107-120. doi:
20	MK Lehtinen, Z Yuan, PR Boag, et al. A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell. 2006;125(5):987-1001.
21	K Willén, A Sroka, RH Takahashi, GK Gouras. Heterogeneous association of Alzheimer's disease-linked amyloid-β and amyloid-β protein precursor with synapses. J Alzheimer's Dis. 2017;60(2):511-524.
22	H Huang, S Nie, M Cao, et al. Characterization of AD-like phenotype in aged APPSwe/PS1dE9 mice. Age (Dordrecht, Netherlands). 2016;38(4):303-322.
23	S Jevtic, AS Sengar, MW Salter, J McLaurin. The role of the immune system in Alzheimer's disease: etiology and treatment. Ageing Res Rev. 2017;40:84-94.
24	Y Xia, N Liu, X Xie, et al. The macrophage-specific V-ATPase subunit ATP6V0D2 restricts inflammasome activation and bacterial infection by facilitating autophagosome-lysosome fusion. Autophagy. 2019;15(6):960-975.
25	AMA Anthony Jalin, R Jin, M Wang, G Li. EPPS treatment attenuates traumatic brain injury in mice by reducing Aβ burden and ameliorating neuronal autophagic flux. Exp Neurol. 2019;314:20-33.
26	JH Lee, WH Yu, A Kumar, et al. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell. 2010;141(7):1146-1158.
27	R Vassar, DM Kovacs, R Yan, PC Wong. The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential. J Neurosci. 2009;29(41):12787-12794.
28	N Matsumoto, M Nakanishi-Matsui. Proton pumping V-ATPase inhibitor bafilomycin A1 affects Rab7 lysosomal localization and abolishes anterograde trafficking of osteoclast secretory lysosomes. Biochem Biophys Res Commun. 2019;510(3):421-426.
29	P Licznerski, V Duric, M Banasr, et al. Decreased SGK1 expression and function contributes to behavioral deficits induced by traumatic stress. PLoS Biol. 2015;13(10):e1002282.
30	A Brunet, J Park, H Tran, LS Hu, BA Hemmings, ME Greenberg. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol. 2001;21(3):952-965.
31	W Qin, W Zhao, L Ho, et al. Regulation of forkhead transcription factor FoxO3a contributes to calorie restriction-induced prevention of Alzheimer's disease-type amyloid neuropathology and spatial memory deterioration. Ann N Y Acad Sci. 2008;1147:335-347.
32	Y Xie, D Jiang, J Xiao, et al. Ischemic preconditioning attenuates ischemia/reperfusion-induced kidney injury by activating autophagy via the SGK1 signaling pathway. Cell Death Dis. 2018;9(3):338.
33	C Shi, J Zhu, S Leng, D Long, X Luo. Mitochondrial FOXO3a is involved in amyloid β peptide-induced mitochondrial dysfunction. J Bioenerg Biomembr. 2016;48(3):189-196.
34	C Shi, K Viccaro, HG Lee, K Shah. Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models. J Cell Sci. 2016;129(9):1815-1830.
35	P Sanphui, SC Biswas. FoxO3a is activated and executes neuron death via Bim in response to β-amyloid. Cell Death Dis. 2013;4(5):e625.
36	JL Jankowsky, DJ Fadale, J Anderson, et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet. 2004;13(2):159-170.
37	D Szklarczyk, AL Gable, D Lyon, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607-d613.
38	P Shannon, A Markiel, O Ozier, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498-2504.
39	M Xu, DF Zhang, R Luo, et al. A systematic integrated analysis of brain expression profiles reveals YAP1 and other prioritized hub genes as important upstream regulators in Alzheimer's disease. Alzheimers Dementia. 2018;14(2):215-229.